Loading clinical trials...

Phase 1b Trial of BGJ398/BYL719 in Solid Tumors | Clinical Trials | Clareo Health

COMPLETEDPhase 1NCT01928459

Phase 1b Trial of BGJ398/BYL719 in Solid Tumors

To study the safety and efficacy of the combination of BGJ398 with BYL719 in patients whose tumors express mutations to PIK3CA with or without alterations to FGFR 1-3.

Lead sponsor: Novartis Pharmaceuticals•7 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 1/2

Phase 1/2 Study of EB-NK-301 (Allogeneic TROP2-CAR NK Cells) in Advanced TROP2-Expressing Solid Tumors

NCT07589530 · Advanced Solid Tumors, Metastatic Solid Tumors, and more

RECRUITINGPhase 1

A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.

NCT07042100 · Advanced Solid Tumors

RECRUITINGPhase 1

A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers With Specific Genetic Changes Called KRASG12C Mutation

NCT06659341 · Advanced Solid Tumors Harboring KRAS G12C Mutation

RECRUITINGPhase 1

A Study of SKB107 in Advanced Solid Tumors With Bone Metastases

NCT07087197 · Metastatic Solid Tumors

RECRUITINGPhase 1/2

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

NCT07335497 · Locally Advanced / Metastatic Solid Tumors

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 9, 2020Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment62

Start dateOct 2013

Last updatedDec 9, 2020

Condition

Advanced Solid Tumors Metastatic Solid Tumors

Locations shown

H. Lee Moffitt Cancer Center & Research Institute Moffitt 4

Tampa, Florida

University of Michigan Comprehensive Cancer Center SC

Ann Arbor, Michigan

Karmanos Cancer Institute Dept of Onc

Detroit, Michigan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 9, 2020Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Phase 1b Trial of BGJ398/BYL719 in Solid Tumors

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Phase 1/2 Study of EB-NK-301 (Allogeneic TROP2-CAR NK Cells) in Advanced TROP2-Expressing Solid Tumors

A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.

A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers With Specific Genetic Changes Called KRASG12C Mutation

A Study of SKB107 in Advanced Solid Tumors With Bone Metastases

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Trial snapshot

Condition

Locations shown

For caregivers